InMode to Participate in the 13th Annual BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
InMode (Nasdaq: INMD) will participate in the 13th Annual BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference in Snowbird, UT. Yair Malca, Chief Financial Officer, will host investor meetings on Wednesday, February 11, 2026. Interested investors should contact their BTIG salesperson to schedule a meeting and may visit InMode's investor relations site for event details.
Details
News Market Reaction – INMD
On Feb 3, the day this news came out, INMD closed 4.33% below the previous close.
Data tracked by StockTitan Argus for the Feb 3 session.
Key Figures
- Conference edition
- 13th annual
- BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference
- Conference date
- February 11, 2026
- BTIG conference investor meetings in Snowbird, UT
Historical Context
-
51% acquisition proposal at $18 per share premium to prior price.
-
Preliminary Q4/FY2025 results and FY2026 revenue guidance announcement.
-
Q3 2025 results with lower revenue year over year and reaffirmed guidance.
-
Appointment of Michael Dennison as President of North America.
-
Planned participation in three November 2025 investor conferences.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
YOKNEAM,
Interested investors are welcome to contact their BTIG salesperson and schedule a meeting.
For more information about the event, visit InMode's investor relations site here.
About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.
Investor Relations Contact:
Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com
Photo - https://mma.prnewswire.com/media/1064477/5747577/InMode_Logo.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/inmode-to-participate-in-the-13th-annual-btig-medtech-digital-health-life-sciences--diagnostics-tools-conference-302676552.html
SOURCE InMode Ltd.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.